+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Cancer Immunotherapy Market by Product Type, Application, End Users, and Geography - Global Forecast up to 2026

  • ID: 5446341
  • Report
  • May 2021
  • Region: Global
  • 89 Pages
  • Infoholic Research LLP
10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

FEATURED COMPANIES

  • Advaxis Inc.
  • AstraZeneca plc
  • Bayer AG
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • Immunomedics Inc.
10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

Cancer Immunotherapy Market Based on Product Type (Monoclonal Antibodies, Cancer Vaccines, Check Point Inhibitors and Immunomodulators), Application (Lung cancer, Breast cancer, Head and neck cancer, Prostate cancer, Colorectal cancer, Melanoma, and Others), End Users (Hospitals & clinic and Diagnostic centers) and Geography - Global Forecast up to 2026
Immunotherapy is a type of treatment to cure cancer that utilizes a few parts of a person’s immune system to fight cancer. This can be either done by enhancing one’s immune system to function with more effort and smarter to kill cancer cells or by providing one’s immune system components, such as human-made immune system proteins. Immunotherapy is a kind of biological therapy. The Cancer Immunotherapy Market is projected to grow at the rate of 9.7% CAGR by 2026. The cancer immunotherapy market growth is majorly attributed to some of the key factors, which include the increasing incidences of cancer, rising awareness about the early diagnosis among cancer patients, efficacy of the therapy compared to other therapies, and surging population of geriatric. On the other hand, the factors restricting the cancer immunotherapy market growth are high costs incurred in the treatment and the development of new drugs.

Cancer Immunotherapy Market segmentation by Product Type


  • Monoclonal Antibodies
  • Cancer Vaccines
  • Check Point Inhibitors
  • Immunomodulators

Cancer Immunotherapy Market segmentation by Application


  • Lung cancer
  • Breast cancer
  • Head and neck cancer
  • Prostate cancer
  • Colorectal cancer
  • Melanoma
  • Others

Cancer Immunotherapy Market segmentation by End Users


  • Hospitals & clinic
  • Diagnostic centers

Cancer Immunotherapy Market segmentation by Geography


  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

The product type segment of the cancer immunotherapy market is sub-segmented as Monoclonal Antibodies, Cancer Vaccines, Check Point Inhibitors, and Immunomodulators. Among all product types, the monoclonal segments are having a key share in the market. Rising investments in research and development of monoclonal antibodies since naked antigen-binding antibodies, conjugated monoclonal antibodies, and bispecific antibodies have opened new revenue creation paths for companies that offer oncology therapeutics. These R&D activities lead to the emergence of monoclonal antibodies, and owing to various benefits of mAbs; they are being examined for various treatments.

If analyzed by the application, the immunotherapy treatment is majorly used to treat lung cancer. The lung cancer segment has the maximum share occupied in the cancer immunotherapy market. This is due to the rising number of lung cancer cases among the public and the increasing number of smokers worldwide, which is a significant cause of lung cancer.

As per the end-user, the cancer immunotherapy market is majorly bifurcated into hospitals & clinics, and diagnostic centers. The hospitals & clinics segment is anticipated to have the fastest growth due to the rising patient pool. Most of the hospitals, specifically in cancer immunotherapy, focus on the treatment of symptomatic conditions. The hospitals and clinics offer cutting-edge treatments which use a patient's immune system to fight cancer. These include cellular therapies, cancer vaccines, and other experimental drugs.

As observed, the North American region is dominating the cancer immunotherapy market due to the rising demand for immunotherapy, increased technological advancements in cancer treatment, and the increasing rate of cancer in this region. Thus factors mentioned above are mainly contributing to the market growth.

Immunotherapies in the pipeline are happening to provide more treatment choices and better results than prevailing therapies. The advent of new drug classes, including monoclonal antibodies and histone deacetylase (HDAC) inhibitors, designed to target receptors associated with multiple myeloma, is expected to build the market's future. Studies on similar drugs aim to reduce adverse effects and spur the market's growth.

These are the primary cancer immunotherapy market players -Merck & Co., Inc., Novartis Pharmaceuticals Corporation, F. Hoffmann-La Roche AG, Advaxis Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Pfizer Inc., Bayer AG, Immunomedics Inc., and AstraZeneca plc.

Hence, cancer immunotherapy is observed to be playing a crucial role in cancer treatment. With the considerable pressure of increasing cancer cases and the side effects of other therapies, cancer immunotherapy has exhibited tremendous potential over the past few years.

  • The profiles of key vendors are presented in the report coupled with their latest developments, which gives a better perception of the competition
  • The report also gives a complete perception of the cancer immunotherapy market with the insights such as drivers, opportunities, challenges, trends, and growth of the market.
  • This report also depicts the key factors and challenges encountered by the key vendors and the forthcoming impact of the restraints and opportunities on the key players.
  • Further entails analyzing the past and presenting cancer immunotherapy market size and further penetrating the market worldwide.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Advaxis Inc.
  • AstraZeneca plc
  • Bayer AG
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • Immunomedics Inc.
1. Executive Summary

2. Industry Outlook
2.1. Industry Overview
2.2. Industry Trends

3. Market Snapshot
3.1. Market Definition
3.2. Market Outlook
3.2.1. Porter Five Forces
3.3. Related Markets

4. Market characteristics
4.1. Market Overview
4.2. Market Segmentation
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. DRO - Impact Analysis

5. Product Type: Market Size & Analysis
5.1. Overview
5.2. Monoclonal Antibodies
5.3. Cancer Vaccines
5.4. Check Point Inhibitors
5.5. Immunomodulators

6. Application: Market Size & Analysis
6.1. Overview
6.2. Lung cancer
6.3. Breast cancer
6.4. Head and neck cancer
6.5. Prostate cancer
6.6. Colorectal cancer
6.7. Melanoma
6.8. Others

7. End Users: Market Size & Analysis
7.1. Overview
7.2. Hospitals & clinic
7.3. Diagnostic centers

8. Geography: Market Size & Analysis
8.1. Overview
8.2. North America
8.3. Europe
8.4. Asia Pacific
8.5. Rest of the World

9. Competitive Landscape
9.1. Competitor Comparison Analysis
9.2. Market Developments
9.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
9.2.2. Product Launches and execution

10. Vendor Profiles
10.1. Merck & Co., Inc.
10.1.1. Overview
10.1.2. Financial Overview
10.1.3. Product Offerings
10.1.4. Developments
10.1.5. Business Strategy
10.2. Novartis Pharmaceuticals Corporation
10.2.1. Overview
10.2.2. Financial Overview
10.2.3. Product Offerings
10.2.4. Developments
10.2.5. Business Strategy
10.3. F. Hoffmann-La Roche AG, Advaxis Inc.
10.3.1. Overview
10.3.2. Financial Overview
10.3.3. Product Offerings
10.3.4. Developments
10.3.5. Business Strategy
10.4. Advaxis Inc.
10.4.1. Overview
10.4.2. Financial Overview
10.4.3. Product Offerings
10.4.4. Developments
10.4.5. Business Strategy
10.5. Bristol-Myers Squibb Company
10.5.1. Overview
10.5.2. Financial Overview
10.5.3. Product Offerings
10.5.4. Developments
10.5.5. Business Strategy
10.6. Eli Lilly and Company
10.6.1. Overview
10.6.2. Financial Overview
10.6.3. Product Offerings
10.6.4. Developments
10.6.5. Business Strategy
10.7. Pfizer Inc.
10.7.1. Overview
10.7.2. Financial Overview
10.7.3. Product Offerings
10.7.4. Developments
10.7.5. Business Strategy
10.8. Bayer AG
10.8.1. Overview
10.8.2. Financial Overview
10.8.3. Product Offerings
10.8.4. Developments
10.8.5. Business Strategy
10.9. Immunomedics Inc.
10.9.1. Overview
10.9.2. Financial Overview
10.9.3. Product Offerings
10.9.4. Developments
10.9.5. Business Strategy
10.10. AstraZeneca plc.
10.10.1. Overview
10.10.2. Financial Overview
10.10.3. Product Offerings
10.10.4. Developments
10.10.5. Business Strategy

11. Analyst Opinion

12. Annexure
12.1. Report Scope
12.2. Market Definitions
12.3. Research Methodology
12.3.1. Data Collation and In-house Estimation
12.3.2. Market Triangulation
12.3.3. Forecasting
12.4. Report Assumptions
12.5. Declarations
12.6. Stakeholders
12.7. Abbreviations

List of Tables
Table 1. Global Cancer Immunotherapy Market Value, by Product Type, 2020-2026 (USD Billion)
Table 2. Global Cancer Immunotherapy Market Value for Monoclonal Antibodies, by Geography, 2020-2026 (USD Billion)
Table 3. Global Cancer Immunotherapy Market Value for Cancer Vaccines, by Geography, 2020-2026 (USD Billion)
Table 4. Global Cancer Immunotherapy Market Value for Checkpoint Inhibitors, by Geography, 2020-2026 (USD Billion)
Table 5. Global Cancer Immunotherapy Market Value for Immunomodulators, by Geography, 2020-2026 (USD Billion)
Table 6. Global Cancer Immunotherapy Market Value, by Application, by Geography, 2020-2026 (USD Billion)
Table 7. Global Cancer Immunotherapy Market Value for Lung Cancer, by Geography, 2020-2026 (USD Billion)
Table 8. Global Cancer Immunotherapy Market Value for Breast Cancer, by Geography, 2020-2026 (USD Billion)
Table 9. Global Cancer Immunotherapy Market Value for Head And Neck Cancer, by Geography, 2020-2026 (USD Billion)
Table 10. Global Cancer Immunotherapy Market Value for Prostate Cancer, by Geography, 2020-2026 (USD Billion)
Table 11. Global Cancer Immunotherapy Market Value for Colorectal Cancer, by Geography, 2020-2026 (USD Billion)
Table 12. Global Cancer Immunotherapy Market Value for Melanoma, by Geography, 2020-2026 (USD Billion)
Table 13. Global Cancer Immunotherapy Market Value for Others, by Geography, 2020-2026 (USD Billion)
Table 14. Global Cancer Immunotherapy Market Value, by End Users, 2020-2026 (USD Billion)
Table 15. Global Cancer Immunotherapy Market Value for Hospitals & Clinic, by Geography, 2020-2026 (USD Billion)
Table 16. Global Cancer Immunotherapy Market Value for Diagnostic Centers, by Geography, 2020-2026 (USD Billion)
Table 17. North America Cancer Immunotherapy Market Value, by Country, 2020-2026 (USD Billion)
Table 18. North America Cancer Immunotherapy Market Value, by Product Type, 2020-2026 (USD Billion)
Table 19. North America Cancer Immunotherapy Market Value, by Application, 2020-2026 (USD Billion)
Table 20. North America Cancer Immunotherapy Market Value, by End Users, 2020-2026 (USD Billion)
Table 21. U.S Cancer Immunotherapy Market Value, by Product Type, 2020-2026 (USD Billion)
Table 22. U.S Cancer Immunotherapy Market Value, by Application, 2020-2026 (USD Billion)
Table 23. U.S Cancer Immunotherapy Market Value, by End Users, 2020-2026 (USD Billion)
Table 24. Canada Cancer Immunotherapy Market Value, by Product Type, 2020-2026 (USD Billion)
Table 25. Canada Cancer Immunotherapy Market Value, by Application, 2020-2026 (USD Billion)
Table 26. Canada Cancer Immunotherapy Market Value, by End Users, 2020-2026 (USD Billion)
Table 27. Europe Cancer Immunotherapy Market Value, by Country, 2020-2026 (USD Billion)
Table 28. Europe Cancer Immunotherapy Market Value, by Product Type, 2020-2026 (USD Billion)
Table 29. Europe Cancer Immunotherapy Market Value, by Application, 2020-2026 (USD Billion)
Table 30. Europe Cancer Immunotherapy Market Value, End Users, 2020-2026 (USD Billion)
Table 31. Germany Cancer Immunotherapy Market Value, by Product Type, 2020-2026 (USD Billion)
Table 32. Germany Cancer Immunotherapy Market Value, by Application, 2020-2026 (USD Billion)
Table 33. Germany Cancer Immunotherapy Market Value, by End Users, 2020-2026 (USD Billion)
Table 34. U.K Cancer Immunotherapy Market Value, by Product Type, 2020-2026 (USD Billion)
Table 35. U.K Cancer Immunotherapy Market Value, by Application, 2020-2026 (USD Billion)
Table 36. U.K Cancer Immunotherapy Market Value, by End Users, 2020-2026 (USD Billion)
Table 37. France Cancer Immunotherapy Market Value, by Product Type, 2020-2026 (USD Billion)
Table 38. France Cancer Immunotherapy Market Value, by Application, 2020-2026 (USD Billion)
Table 39. France Cancer Immunotherapy Market Value, by End Users, 2020-2026 (USD Billion)
Table 40. Italy Cancer Immunotherapy Market Value, by Product Type, 2020-2026 (USD Billion)
Table 41. Italy Cancer Immunotherapy Market Value, by Application, 2020-2026 (USD Billion)
Table 42. Italy Cancer Immunotherapy Market Value, by End Users, 2020-2026 (USD Billion)
Table 43. Spain Cancer Immunotherapy Market Value, by Product Type, 2020-2026 (USD Billion)
Table 44. Spain Cancer Immunotherapy Market Value, by Application, 2020-2026 (USD Billion)
Table 45. Spain Cancer Immunotherapy Market Value, by End Users, 2020-2026 (USD Billion)
Table 46. Roe Cancer Immunotherapy Market Value, by Product Type, 2020-2026 (USD Billion)
Table 47. Roe Cancer Immunotherapy Market Value, by Application, 2020-2026 (USD Billion)
Table 48. Roe Cancer Immunotherapy Market Value, by End Users, 2020-2026 (USD Billion)
Table 49. Asia Pacific Cancer Immunotherapy Market Value, by Country, 2020-2026 (USD Billion)
Table 50. Asia Pacific Cancer Immunotherapy Market Value, by Product Type, 2020-2026 (USD Billion)
Table 51. Asia Pacific Cancer Immunotherapy Market Value, by Application, 2020-2026 (USD Billion)
Table 52. Asia Pacific Cancer Immunotherapy Market Value, by End Users, 2020-2026 (USD Billion)
Table 53. China Cancer Immunotherapy Market Value, by Product Type, 2020-2026 (USD Billion)
Table 54. China Cancer Immunotherapy Market Value, by Application, 2020-2026 (USD Billion)
Table 55. China Cancer Immunotherapy Market Value, by End Users, 2020-2026 (USD Billion)
Table 56. India Cancer Immunotherapy Market Value, by Product Type, 2020-2026 (USD Billion)
Table 57. India Cancer Immunotherapy Market Value, by Application, 2020-2026 (USD Billion)
Table 58. India Cancer Immunotherapy Market Value, by End Users, 2020-2026 (USD Billion)
Table 59. Japan Cancer Immunotherapy Market Value, by Product Type, 2020-2026 (USD Billion)
Table 60. Japan Cancer Immunotherapy Market Value, by Application, 2020-2026 (USD Billion)
Table 61. Japan Cancer Immunotherapy Market Value, by End Users, 2020-2026 (USD Billion)
Table 62. Rest of APAC Cancer Immunotherapy Market Value, by Product Type, 2020-2026 (USD Billion)
Table 63. Rest of APAC Cancer Immunotherapy Market Value, by Application, 2020-2026 (USD Billion)
Table 64. Rest of APAC Cancer Immunotherapy Market Value, by End Users, 2020-2026 (USD Billion)
Table 65. Rest of World Cancer Immunotherapy Market Value, by Product Type, 2020-2026 (USD Billion)
Table 66. Rest of World Cancer Immunotherapy Market Value, by Application, 2020-2026 (USD Billion)
Table 67. Rest of World Cancer Immunotherapy Market Value, by End Users, 2020-2026 (USD Billion)
Table 68. Merck & Co., Inc: Financials
Table 69. Merck & Co., Inc: Products & Services
Table 70. Merck & Co., Inc: Recent Developments
Table 71. Novartis Pharmaceuticals Corporation: Financials
Table 72. Novartis Pharmaceuticals Corporation: Products & Services
Table 73. Novartis Pharmaceuticals Corporation: Recent Developments
Table 74. F. Hoffmann-La Roche AG: Financials
Table 75. F. Hoffmann-La Roche AG: Products & Services
Table 76. F. Hoffmann-La Roche AG: Recent Developments
Table 77. Advaxis Inc: Financials
Table 78. Advaxis Inc: Products & Services
Table 79. Advaxis Inc: Recent Developments
Table 80. Bristol-Myers Squibb Company: Financials
Table 81. Bristol-Myers Squibb Company: Products & Services
Table 82. Bristol-Myers Squibb Company: Recent Developments
Table 83. Eli Lilly And Company: Financials
Table 84. Eli Lilly And Company: Products & Services
Table 85. Eli Lilly And Company: Recent Developments
Table 86. Pfizer Inc: Financials
Table 87. Pfizer Inc: Products & Services
Table 88. Pfizer Inc: Recent Developments
Table 89. Bayer AG: Financials
Table 90. Bayer AG: Products & Services
Table 91. Bayer AG: Recent Developments
Table 92. Immunomedics Inc: Financials
Table 93. Immunomedics Inc: Products & Services
Table 94. Immunomedics Inc: Recent Developments
Table 95. Astrazeneca Plc: Financials
Table 96. Astrazeneca Plc: Products & Services
Table 97. Astrazeneca Plc: Recent Developments

List of Figures
Chart. 1. Global Cancer Immunotherapy Market Value, by Product Type, 2020-2026 (USD Billion)
Chart 2. Global Cancer Immunotherapy Market Value for Monoclonal Antibodies, by Geography, 2020-2026 (USD Billion)
Chart 3. Global Cancer Immunotherapy Market Value for Cancer Vaccines, by Geography, 2020-2026 (USD Billion)
Chart 4. Global Cancer Immunotherapy Market Value for Checkpoint Inhibitors, by Geography, 2020-2026 (USD Billion)
Chart 5. Global Cancer Immunotherapy Market Value for Immunomodulators, by Geography, 2020-2026 (USD Billion)
Chart 6. Global Cancer Immunotherapy Market Value, by Application, by Geography, 2020-2026 (USD Billion)
Chart 7. Global Cancer Immunotherapy Market Value for Lung Cancer, by Geography, 2020-2026 (USD Billion)
Chart 8. Global Cancer Immunotherapy Market Value for Breast Cancer, by Geography, 2020-2026 (USD Billion)
Chart 9. Global Cancer Immunotherapy Market Value for Head And Neck Cancer, by Geography, 2020-2026 (USD Billion)
Chart 10. Global Cancer Immunotherapy Market Value for Prostate Cancer, by Geography, 2020-2026 (USD Billion)
Chart 11. Global Cancer Immunotherapy Market Value for Colorectal Cancer, by Geography, 2020-2026 (USD Billion)
Chart 12. Global Cancer Immunotherapy Market Value for Melanoma, by Geography, 2020-2026 (USD Billion)
Chart 13. Global Cancer Immunotherapy Market Value for Others, by Geography, 2020-2026 (USD Billion)
Chart 14. Global Cancer Immunotherapy Market Value, by End Users, 2020-2026 (USD Billion)
Chart 15. Global Cancer Immunotherapy Market Value for Hospitals & Clinic, by Geography, 2020-2026 (USD Billion)
Chart 16. Global Cancer Immunotherapy Market Value for Diagnostic Centers, by Geography, 2020-2026 (USD Billion)
Chart 17. North America Cancer Immunotherapy Market Value, by Country, 2020-2026 (USD Billion)
Chart 18. North America Cancer Immunotherapy Market Value, by Product Type, 2020-2026 (USD Billion)
Chart 19. North America Cancer Immunotherapy Market Value, by Application, 2020-2026 (USD Billion)
Chart 20. North America Cancer Immunotherapy Market Value, by End Users, 2020-2026 (USD Billion)
Chart 21. U.S Cancer Immunotherapy Market Value, by Product Type, 2020-2026 (USD Billion)
Chart 22. U.S Cancer Immunotherapy Market Value, by Application, 2020-2026 (USD Billion)
Chart 23. U.S Cancer Immunotherapy Market Value, by End Users, 2020-2026 (USD Billion)
Chart 24. Canada Cancer Immunotherapy Market Value, by Product Type, 2020-2026 (USD Billion)
Chart 25. Canada Cancer Immunotherapy Market Value, by Application, 2020-2026 (USD Billion)
Chart 26. Canada Cancer Immunotherapy Market Value, by End Users, 2020-2026 (USD Billion)
Chart 27. Europe Cancer Immunotherapy Market Value, by Country, 2020-2026 (USD Billion)
Chart 28. Europe Cancer Immunotherapy Market Value, by Product Type, 2020-2026 (USD Billion)
Chart 29. Europe Cancer Immunotherapy Market Value, by Application, 2020-2026 (USD Billion)
Chart 30. Europe Cancer Immunotherapy Market Value, End Users, 2020-2026 (USD Billion)
Chart 31. Germany Cancer Immunotherapy Market Value, by Product Type, 2020-2026 (USD Billion)
Chart 32. Germany Cancer Immunotherapy Market Value, by Application, 2020-2026 (USD Billion)
Chart 33. Germany Cancer Immunotherapy Market Value, by End Users, 2020-2026 (USD Billion)
Chart 34. U.K Cancer Immunotherapy Market Value, by Product Type, 2020-2026 (USD Billion)
Chart 35. U.K Cancer Immunotherapy Market Value, by Application, 2020-2026 (USD Billion)
Chart 36. U.K Cancer Immunotherapy Market Value, by End Users, 2020-2026 (USD Billion)
Chart 37. France Cancer Immunotherapy Market Value, by Product Type, 2020-2026 (USD Billion)
Chart 38. France Cancer Immunotherapy Market Value, by Application, 2020-2026 (USD Billion)
Chart 39. France Cancer Immunotherapy Market Value, by End Users, 2020-2026 (USD Billion)
Chart 40. Italy Cancer Immunotherapy Market Value, by Product Type, 2020-2026 (USD Billion)
Chart 41. Italy Cancer Immunotherapy Market Value, by Application, 2020-2026 (USD Billion)
Chart 42. Italy Cancer Immunotherapy Market Value, by End Users, 2020-2026 (USD Billion)
Chart 43. Spain Cancer Immunotherapy Market Value, by Product Type, 2020-2026 (USD Billion)
Chart 44. Spain Cancer Immunotherapy Market Value, by Application, 2020-2026 (USD Billion)
Chart 45. Spain Cancer Immunotherapy Market Value, by End Users, 2020-2026 (USD Billion)
Chart 46. RoE Cancer Immunotherapy Market Value, by Product Type, 2020-2026 (USD Billion)
Chart 47. RoE Cancer Immunotherapy Market Value, by Application, 2020-2026 (USD Billion)
Chart 48. RoE Cancer Immunotherapy Market Value, by End Users, 2020-2026 (USD Billion)
Chart 49. Asia Pacific Cancer Immunotherapy Market Value, by Country, 2020-2026 (USD Billion)
Chart 50. Asia Pacific Cancer Immunotherapy Market Value, by Product Type, 2020-2026 (USD Billion)
Chart 51. Asia Pacific Cancer Immunotherapy Market Value, by Application, 2020-2026 (USD Billion)
Chart 52. Asia Pacific Cancer Immunotherapy Market Value, by End Users, 2020-2026 (USD Billion)
Chart 53. China Cancer Immunotherapy Market Value, by Product Type, 2020-2026 (USD Billion)
Chart 54. China Cancer Immunotherapy Market Value, by Application, 2020-2026 (USD Billion)
Chart 55. China Cancer Immunotherapy Market Value, by End Users, 2020-2026 (USD Billion)
Chart 56. India Cancer Immunotherapy Market Value, by Product Type, 2020-2026 (USD Billion)
Chart 57. India Cancer Immunotherapy Market Value, by Application, 2020-2026 (USD Billion)
Chart 58. India Cancer Immunotherapy Market Value, by End Users, 2020-2026 (USD Billion)
Chart 59. Japan Cancer Immunotherapy Market Value, by Product Type, 2020-2026 (USD Billion)
Chart 60. Japan Cancer Immunotherapy Market Value, by Application, 2020-2026 (USD Billion)
Chart 61. Japan Cancer Immunotherapy Market Value, by End Users, 2020-2026 (USD Billion)
Chart 62. Rest of APAC Cancer Immunotherapy Market Value, by Product Type, 2020-2026 (USD Billion)
Chart 63. Rest of APAC Cancer Immunotherapy Market Value, by Application, 2020-2026 (USD Billion)
Chart 64. Rest of APAC Cancer Immunotherapy Market Value, by End Users, 2020-2026 (USD Billion)
Chart 65. Rest of World Cancer Immunotherapy Market Value, by Product Type, 2020-2026 (USD Billion)
Chart 66. Rest of World Cancer Immunotherapy Market Value, by Application, 2020-2026 (USD Billion)
Chart 67. Rest of World Cancer Immunotherapy Market Value, by End Users, 2020-2026 (USD Billion)
Note: Product cover images may vary from those shown
  • Merck & Co. Inc.
  • Novartis Pharmaceuticals Corporation
  • F. Hoffmann-La Roche AG
  • Advaxis Inc.
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • Pfizer Inc.
  • Bayer AG
  • Immunomedics Inc.
  • AstraZeneca plc
Note: Product cover images may vary from those shown